Actis to invest more than $700m to develop life sciences realty assets in India

Actis has plans to invest more than $700 million to develop and expand its life sciences realty portfolio, reported Economic Times (ET).

“India’s life sciences sector holds huge potential for growth in the current decade, with a large talent pool at significantly competitive cost making it a compelling destination for global research & development (R&D) and manufacturing,” Ashish Singh, partner and Head of India and SE Asia Real Estate at Actis, told ET.

The strategy follows Actis’s acquisition of Rx Propellant, a platform focused on providing real estate solutions (R&D labs and associated facilities) to tenants in the life sciences and related sectors in India. Rx Propellant is currently involved in development and marketing of a number of real e